CAS 2167246-24-2

Formule : C18H24F2N6O

InChI : InChI=1S/C18H24F2N6O/c1-13-4-7-26(24-13)17-22-15(21-14-2-5-18(19,20)6-3-14)12-16(23-17)25-8-10-27-11-9-25/h4,7,12,14H,2-3,5-6,8-11H2,1H3,(H,21,22,23)

Code InChI : OVLIDRAJVMUEMC-UHFFFAOYSA-N

SMILES : CC1=NN(C=C1)C2=NC(=CC(=N2)N3CCOCC3)NC4CCC(CC4)(F)F

Rimtuzalcap

CAS : 2167246-24-2

Rimtuzalcap

Formule : C₁₈H₂₄F₂N₆O

Degré de pureté : ≥98%

Masse moléculaire : 378.42

Ref: 54-BUP07975

N-(4,4-Difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine

CAS : 2167246-24-2

Formule : C₁₈H₂₄F₂N₆O

Masse moléculaire : 378.4196

Ref: IN-DA023OG5

Rimtuzalcap

CAS : 2167246-24-2

N-(4,4-Difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-morpholinopyrimidin-4-amine

Formule : C₁₈H₂₄F₂N₆O

Degré de pureté : 95%

Masse moléculaire : 378.42

Ref: IN-DG01449724

Rimtuzalcap

CAS : 2167246-24-2

Rimtuzalcap (CAD-1883), a selective modulator for SK channels, may treat movement disorders like SCA and ET.

Formule : C₁₈H₂₄F₂N₆O

Degré de pureté : 99.64%

Couleur et forme : Solid

Masse moléculaire : 378.4196

Ref: TM-T9522

Rimtuzalcap

CAS : 2167246-24-2

Rimtuzalcap is a monoclonal antibody, which is derived from a hybridoma technology involving the fusion of specific immune cells. It operates through the highly specific binding to a targeted antigen, thereby modulating immune responses or interfering with signaling pathways. This precision in action enhances its efficacy and minimizes off-target effects compared to broader immunomodulatory agents.

Formule : C₁₈H₂₄F₂N₆O

Degré de pureté : Min. 95%

Masse moléculaire : 378.42 g/mol

Ref: 3D-BR184195